K

E

Euclidean Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Series A

Z
Zeitview

Visual AI • Critical Infrastructure

Climate Investment logo
Y Combinator logo
Valor Equity Partners logo
Upfront Ventures logo

Zeitview provides a visual AI platform for inspecting and analyzing critical infrastructure across various sectors like solar, wind, utilities, properties, and telecom.

Equity
$60M
03/05/2025
Article
L
Leal Therapeutics

Biotechnology • Central Nervous System

Chugai Venture Fund logo
Newpath Partners logo
PhiFund logo
OrbiMed logo

Leal Therapeutics is a biotechnology company developing treatments for central nervous system disorders, focusing on amyotrophic lateral sclerosis (ALS) and schizophrenia.

Equity
$45M
10/30/2024
Article
N
Nura Bio

Neuroprotective therapies • Neurological diseases

The Column Group logo
Sanofi Ventures logo
Samsara Bio Capital logo
Euclidean Capital logo

Nura Bio Inc. develops neuroprotective therapies for neurological diseases, with a focus on advancing their lead candidate, a brain-penetrant SARM1 inhibitor.

Series A
$68M
09/17/2024
Article
C
Circle Pharma

Biopharmaceutical • Clinical development

The Column Group logo
Nextech Invest logo
Euclidean Capital logo

Circle Pharma is a biopharmaceutical company developing cell-permeable macrocycle treatments for cancer and other serious diseases.

Series D
$90M
09/03/2024
Article
A
Actio Biosciences

Biotechnology • Precision Medicine

Canaan logo
DROIA Ventures logo
EcoR1 logo
Euclidean Capital logo

Actio Biosciences is a biotechnology company that uses its proprietary platform for genetics and precision medicine to develop therapeutics for both rare and common diseases, with a focus on TRPV4 mutations for the treatment of Charcot-Marie-Tooth disease type 2C and other serious bone diseases.

Series A
$55M
09/12/2023
Article